Alignment Healthcare EVP sells 23.5K shares at $8.61

EVP and director Joseph S. Konowiecki sold shares of ALHC to cover tax withholding from RSU vesting and continues to hold over one million shares.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) reported that EVP, Corporate Affairs Joseph S. Konowiecki, a director and officer, sold 23,511 shares of common stock on September 17, 2026 at a weighted-average price of $8.61 per share. According to the disclosure, the sale was made to cover tax withholding obligations arising from the vesting of restricted stock units and is described as not a discretionary trade. Following this transaction, Konowiecki directly holds 1,080,305 shares of Alignment Healthcare common stock.

Insider Trade Summary

Net Seller: 23,511 shares

Net Sell 1 txn

Insider KONOWIECKI JOSEPH S

Role EVP, Corporate Affairs

Sold 23,511 shs ($202K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	23,511	$8.61	$202K

Holdings After Transaction: Common Stock — 1,080,305 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.285 to $8.915. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Key Figures

Shares sold: 23,511 shares Weighted-average sale price: $8.61 per share Sale price range: $8.285–$8.915 per share +2 more

5 metrics

Shares sold 23,511 shares Common stock sale by Joseph S. Konowiecki on September 17, 2026

Weighted-average sale price $8.61 per share Average price for 23,511 ALHC shares sold on September 17, 2026

Sale price range $8.285–$8.915 per share Range of prices for multiple sale transactions included in the Form 4

Shares held after transaction 1,080,305 shares Direct ALHC holdings of Joseph S. Konowiecki following the sale

Transaction date September 17, 2026 Date of the reported sale of ALHC common stock

Key Terms

restricted stock units, tax withholding obligations, weighted-average price

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"sold by the reporting person to cover tax withholding obligations"

weighted-average price financial

"The reported price in column 4 is a weighted-average price"

Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ALHC report for Joseph S. Konowiecki?

ALHC reported that Joseph S. Konowiecki sold 23,511 shares of common stock on September 17, 2026 to cover tax withholding obligations related to vesting restricted stock units. The filing states this was not a discretionary trade.

At what price were the ALHC shares sold in this Form 4 transaction?

The reported transaction shows a weighted-average price of $8.61 per share. Footnote disclosure states the shares were sold in multiple trades at prices ranging from $8.285 to $8.915 per share.

How many ALHC shares does Joseph S. Konowiecki hold after this sale?

After the reported sale, Joseph S. Konowiecki directly holds 1,080,305 shares of Alignment Healthcare, Inc. common stock, according to the Form 4 disclosure.

Why did the ALHC insider sell 23,511 shares?

The filing states the 23,511 shares were sold to cover tax withholding obligations incurred upon the vesting of restricted stock units. It further notes that this transaction does not represent a discretionary trade by the reporting person.

Was the ALHC insider sale made under a Rule 10b5-1 trading plan?

The Form 4 indicates no Rule 10b5-1 plan is reported via the plan checkbox, and the footnote explains the sale was to satisfy tax withholding obligations associated with restricted stock unit vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 04:30 PM Accepted by SEC EDGAR 09/18/2026 - 04:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KONOWIECKI JOSEPH S

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Affairs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2026		S		23,511(1)	D	$8.61(2)	1,080,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.285 to $8.915. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Joseph S. Konowiecki	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)